Alveolar uptake of lipid and protein components of surfactant

1991 ◽  
Vol 261 (4) ◽  
pp. L334-L340 ◽  
Author(s):  
A. B. Fisher ◽  
C. Dodia ◽  
A. Chander
Keyword(s):  
Plasma Membranes ◽  
Protein A ◽  
Surfactant Protein ◽  
Lung Lavage ◽  
Surfactant Protein A ◽  
Rat Lung ◽  
Protein Breakdown ◽  
Aqueous Fraction ◽  
Natural Surfactant ◽  
Protein Components

We investigated the clearance of radiolabeled natural surfactant from the alveolar space of the isolated perfused rat lung. 3H, 35S-natural surfactant was prepared from rat lungs that had been perfused with [methyl-3H]choline and [35S]methionine. The biosynthesized material contained greater than 95% of 3H in phosphatidylcholine (PC) and approximately 80% of 35S in surfactant protein A. Natural surfactant (1 mumol PC) was instilled into the trachea; lungs were analyzed 5 min later or after 2 h perfusion to determine surfactant uptake, defined as lung lavage-resistant 3H or 35S [% of instilled disintegrations per minute(dpm)]. Uptake at 5 min was 31.4 +/- 0.37% for 3H and 31.9 +/- 0.85% for 35S (mean +/- SE, n = 4). At 2 h, uptake was 46.6 +/- 0.96% for 3H and 45.8 +/- 1.1% for 35S (n = 7). In the presence of 0.1 mM 8-bromoadenosine 3',5'-cyclic monophosphate (8-BrcAMP), uptake at 2 h for both 3H and 35S was stimulated to approximately 57% of instilled dpm (n = 4). Microsomes and plasma membranes isolated from lung homogenates had a ratio of 3H to 35S that was similar to the original surfactant, whereas 3H/35S in isolated lamellar bodies was increased 2.1-fold. Degradation of lipid was indicated by finding 13.4 +/- 0.65% of homogenate 3H in the aqueous fraction of lung extract after 2 h perfusion; only 2.3 +/- 0.47% of 35S dpm were soluble in trichloroacetic acid, suggesting significantly less protein breakdown. Lipid degradation was increased more than twofold by 8-BrcAMP, whereas protein degradation was not changed significantly.(ABSTRACT TRUNCATED AT 250 WORDS)

Localization of surfactant protein A (SP-A) in alveolar macrophage subpopulations of normal and fibrotic rat lung

1994 ◽  
Vol 102 (5) ◽  
pp. 345-352 ◽  
Author(s):  
M. Kasper ◽  
G. Haroske ◽  
D. Schuh ◽  
M. M�ller ◽  
R. Koslowski ◽  
...  
Keyword(s):  
Alveolar Macrophage ◽  
Protein A ◽  
Surfactant Protein ◽  
Surfactant Protein A ◽  
Rat Lung ◽  
Macrophage Subpopulations

ATP and adenosine 3',5'-cyclic monophosphate stimulate the synthesis of surfactant protein A in rat lung

1993 ◽  
Vol 264 (5) ◽  
pp. L431-L437 ◽  
Author(s):  
A. Wali ◽  
M. F. Beers ◽  
C. Dodia ◽  
S. I. Feinstein ◽  
A. B. Fisher
Keyword(s):  
Total Protein ◽  
Protein A ◽  
Lamellar Body ◽  
Surfactant Protein ◽  
Surfactant Protein A ◽  
Enzyme Linked Immunosorbent Assay ◽  
Translational Efficiency ◽  
Rat Lung ◽  
Body Protein ◽  
Cyclic Monophosphate

Synthesis and secretion of surfactant protein A (SP-A) were studied in the isolated perfused rat lung using Trans35S-label (approximately 85% methionine, 15% cysteine) in the perfusate with or without 1 mM ATP or 0.1 mM 8-bromoadenosine 3',5',-cyclic monophosphate (8-BrcAMP) for up to 6 h of perfusion. By enzyme-linked immunosorbent assay, the SP-A content was 36 +/- 0.3% of total protein in extracellular surfactant and 10.8 +/- 1.9% of total protein in lamellar bodies of control lungs; these relativr proportions were maintained in the presence of ATP or 8-BrcAMP. Incorporation of [35S]methionine (cysteine) into the surfactant and lamellar body protein fraction could be detected at 4 h of perfusion. At 6 h, specific activity of total protein [disintegrations per minute (dpm)/micrograms)] was significantly increased in both the surfactant (54%) and lamellar body fractions (30%) under the influence of either secretagogue compared with control conditions. In the presence of ATP, there was a significant increase in the SP-A immunoprecipitable counts of 61 and 72% in extra- and intracellular compartments, respectively. However, no significant change was observed in the relative abundance of SP-A mRNA between control and secretagogue-treated lungs. This dissociation of SP-A mRNA abundance and label incorporation into protein indicates that alteration in translational efficiency or posttranslational factors may be involved in the secretagogue-induced stimulation of SP-A synthesis.

scholarly journals Surfactant protein A is localized at the corners of the pulmonary tubular myelin lattice.

1991 ◽  
Vol 39 (10) ◽  
pp. 1331-1336 ◽  
Author(s):  
W F Voorhout ◽  
T Veenendaal ◽  
H P Haagsman ◽  
A J Verkleij ◽  
L M van Golde ◽  
...  
Keyword(s):  
Protein A ◽  
Surfactant Protein ◽  
Surfactant Protein A ◽  
Alveolar Type ◽  
Type Ii ◽  
Rat Lung ◽  
Lamellar Bodies ◽  
20 Nm

Immunogold labeling on sections of a freeze-substituted tubular myelin-enriched fraction isolated from a bronchoalveolar lavage of rat lung showed that surfactant protein A (SP-A) occurs predominantly at the corners of the tubular myelin lattice. Seventy-nine percent of the gold particles were located within 20 nm from a corner. Extracellular SP-A was detected only in the tubular myelin lattice and not in vesicles or secreted lamellar bodies. Ultra-thin cryosections of rat lung fixed in vivo showed that intracellular SP-A was distributed homogeneously over the stacked membranes of lamellar bodies in alveolar Type II cells. The presence of SP-A at the corners of the tubular myelin lattice suggests an important role of this protein in the formation and/or maintenance of this highly ordered lattice.

Surfactant Protein A Binding to Cytomegalovirus Proteins Enhances Virus Entry into Rat Lung Cells

2000 ◽  
Vol 23 (1) ◽  
pp. 71-78 ◽  
Author(s):  
Christiane Weyer ◽  
Robert Sabat ◽  
Heide Wissel ◽  
Detlev H. Krüger ◽  
Paul A. Stevens ◽  
...  
Keyword(s):  
Virus Entry ◽  
Protein A ◽  
Surfactant Protein ◽  
Surfactant Protein A ◽  
Lung Cells ◽  
Rat Lung

Efficient resolution of Pneumocystis murina infection in surfactant protein A-deficient mice following withdrawal of corticosteroid-induced immunosuppression

2006 ◽  
Vol 55 (2) ◽  
pp. 143-147 ◽  
Author(s):  
Michael Linke ◽  
Alan Ashbaugh ◽  
Judith Koch ◽  
Reiko Tanaka ◽  
Peter Walzer
Keyword(s):  
Protein A ◽  
Lavage Fluid ◽  
Surfactant Protein ◽  
Lung Lavage ◽  
Surfactant Protein A ◽  
Surfactant Protein D ◽  
Wild Type ◽  
Enhanced Expression ◽  
Lymphocyte Populations ◽  
Deficient Mice

Following withdrawal of immunosuppression, surfactant protein A (SP-A)-deficient and wild-type mice cleared Pneumocystis murina infection in a similar manner, but exhibited significant differences in lymphocyte populations, interleukin (IL)-6 levels and chemokine expression levels. A higher percentage of lymphocytes were detected in lung lavage fluid from SP-A-deficient mice, but more CD4+ T cells were isolated from lung tissue of wild-type mice. Higher concentrations of IL-6 were detected in lavage fluid and enhanced expression of lymphotactin and RANTES were detected in the lungs of wild-type mice. Equal levels of surfactant protein D were detected in SP-A-deficient and wild-type mice and no differences were detected in markers of lung injury between the two strains of mice. Thus, SP-A does not enhance organism clearance, but does modulate the host immune response during resolution of P. murina infection.

Surfactant protein A is degraded by alveolar macrophages

1996 ◽  
Vol 271 (2) ◽  
pp. L258-L266 ◽  
Author(s):  
S. R. Bates ◽  
A. B. Fisher
Keyword(s):  
Alveolar Macrophages ◽  
Lung Surfactant ◽  
Protein A ◽  
Surfactant Protein ◽  
Lung Lavage ◽  
Surfactant Protein A ◽  
Cell Association ◽  
Lag Period ◽  
Alveolar Proteinosis ◽  
Lung Surfactant Protein

The metabolism of iodinated lung surfactant protein A (SP-A) by alveolar macrophages in primary culture was examined to determine the role these cells play in the degradation of this surfactant protein. SP-A was isolated from lung lavage obtained from normal bovines, patients with alveolar proteinosis, and silica-treated rats. SP-A (0.5 microgram/ml) was incubated for 3 h with rat alveolar macrophages obtained by lung lavage. Cell association and degradation of human and rat SP-A was three times greater than that of bovine SP-A. During the 3-h period, 50% of total macrophage-associated SP-A was degraded. Degradation was time-, temperature-, and concentration-dependent after a 1-h lag period. SP-A degradation was intracellular, since NH4Cl inhibited degradation > 50%, and macrophage-conditioned medium was ineffective. Tenfold more SP-A was degraded by macrophages than by type II cells isolated after elastase digestion of rat lungs. There was little degradation of SP-A by HeLa cells. We conclude that alveolar macrophages take up and degrade SP-A and thus could contribute to the catabolism of SP-A in the lung.

scholarly journals Pathway to lamellar bodies for surfactant protein A

2010 ◽  
Vol 299 (1) ◽  
pp. L51-L58 ◽  
Author(s):  
Aron B. Fisher ◽  
Chandra Dodia ◽  
Peter Ruckert ◽  
Jian-Qin Tao ◽  
Sandra R. Bates
Keyword(s):  
Specific Activity ◽  
Protein A ◽  
Lamellar Body ◽  
Lavage Fluid ◽  
Surfactant Protein ◽  
Lung Lavage ◽  
Surfactant Protein A ◽  
Coated Vesicle ◽  
Lamellar Bodies ◽  
Vesicle Budding

Alveolar surfactant protein A (SP-A) is endocytosed by type II epithelial cells through clathrin-dependent uptake and targeted to lamellar bodies for resecretion. However, the mechanism for secretion of newly synthesized SP-A, whether regulated exocytosis of lamellar bodies or constitutive secretion, is unresolved. If it is the latter, lamellar body SP-A would represent endocytosed protein. Amantadine, an inhibitor of clathrin-coated vesicle budding, was used to evaluate the role of endocytosis in accumulation of SP-A in lamellar bodies. In isolated rat lungs, amantadine (10 mM) inhibited uptake of endotracheally instilled 35S-labeled biosynthesized surfactant proteins by >80%. To study trafficking of newly synthesized SP-A, lungs were perfused for up to 6 h with [35S]methionine, and surfactant was isolated from lung lavage fluid and lamellar bodies were isolated from lung homogenate. With control lungs, the mean specific activity of [35S]SP-A (disintegrations per minute per microgram of SP-A) increased linearly with time of perfusion: it was significantly higher in isolated lamellar bodies than in surfactant and was increased in both compartments by 50–60% in the presence of 0.1 mM 8-bromo-cAMP. These results suggest a precursor-product relationship between lamellar body and extracellular [35S]SP-A. Specific activities in both compartments were unaffected by addition of amantadine (10 mM) to the lung perfusate, indicating that uptake from the alveolar space was not responsible for the increase in lamellar body [35S]SP-A. Thus the pathway for secretion of newly synthesized SP-A is by transfer from the site of synthesis to the storage/secretory organelle prior to lamellar body exocytosis.

Regulation of surfactant protein A mRNA by hormones and butyrate in cultured fetal rat lung

1990 ◽  
Vol 259 (6) ◽  
pp. L488-L495 ◽  
Author(s):  
K. V. Nichols ◽  
J. Floros ◽  
D. W. Dynia ◽  
S. V. Veletza ◽  
C. M. Wilson ◽  
...  
Keyword(s):  
Protein A ◽  
Surfactant Protein ◽  
Surfactant Protein A ◽  
Rat Lung ◽  
Acid Analogue ◽  
Camp Analogue ◽  
Fetal Rat ◽  
Fetal Rat Lung ◽  
Dose Dependent Fashion ◽  
Diabetic Mothers

We have previously shown that dexamethasone, triiodothyronine (T3) and dibutyryl adenosine 3',5'-cyclic monophosphate (cAMP) stimulate phosphatidylcholine (PC) synthesis in fetal rat lung explants in culture. There are also additive interactions between these agents with regard to PC synthesis. In this study we examined the regulation of surfactant protein A (SP-A) mRNA in fetal rat lung in culture. Dexamethasone increased SP-A mRNA in the explants in a dose-dependent fashion (1–200 nM), but T3 did not. Whereas 8-bromo-cAMP increased SP-A mRNA, a decrease was observed with dibutyryl cAMP. These findings support the view that at least some of the genes involved in the synthesis of the various components of surfactant are independently regulated. Since we observed differences in the effects of a cAMP analogue which contained butyrate and one that did not, explants were then cultured with Na butyrate, a known regulator of gene expression. A significant decrease in SP-A mRNA was observed at mM concentrations. Exposure of the explants to alpha-aminobutyric acid, a butyric acid analogue which is elevated in the blood of infants of diabetic mothers, resulted in a significant decrease in SP-A mRNA at a concentration 1/25 of that required for Na butyrate. This observation raises the question of whether the decreased SP-A levels reported in fetuses of diabetic mothers may, at least in part, be related to this metabolite.

Sign in / Sign up

Export Citation Format

Share Document